Pharmaids Pharmaceuticals Ltd vs DIVI S LABORATORIES LTD

A side-by-side comparison of Pharmaids Pharmaceuticals Ltd (524572) and DIVI S LABORATORIES LTD (DIVISLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, DIVI S LABORATORIES LTD leads 524572 vs DIVISLAB on 10 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth· not comparable
  • Size & financial health04

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

-9.30
P/E ratio
96.86
2.26
P/B ratio
10.62
0.00%
Dividend yield
0.32%
₹-3.32
EPS
₹96.73

Profitability

DIVISLAB takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

-26.50%
Return on equity
16.50%
-19.00%
Return on capital
22.00%
-49.00%
EBITDA margin
33.00%
-42.86%
Net margin
24.32%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y) even
10.78%
Profit CAGR (3Y) even
12.10%

Size & financial health

DIVISLAB takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹108 Cr
Market cap
₹2.49L Cr
₹28 Cr
Revenue
₹10,560 Cr
₹-12 Cr
Net profit
₹2,568 Cr
0.49
Debt / equity
0.00
Pharmaids Pharmaceuticals Ltd
  • + ["Company has reduced debt.", "Company is expected to give good quarter", "Debtor days have improved from 56.1 to 44.9 days."]
  • ["Company has low interest coverage ratio.", "Promoter holding is low: 33.0%", "Company has a low return on equity of -19.4% over last 3 years."]
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 14.8 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
Pharmaids Pharmaceuticals Ltd full analysis DIVI S LABORATORIES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

524572 vs DIVISLAB: Share Price, Valuation & Which to Buy | DocStoX